Cellectar Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cellectar Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q1 2024.
  • Cellectar Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $487K, a 10.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $487K -$59.7K -10.9% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $502K -$58.1K -10.4% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 $518K +$379K +275% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $532K +$371K +230% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $547K +$363K +198% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $560K +$356K +174% Dec 31, 2022 10-K 2024-03-27
Q3 2022 $138K -$87.1K -38.7% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $161K -$83.9K -34.2% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $183K -$80.8K -30.6% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $205K -$77.7K -27.5% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $225K -$74.8K -24.9% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $245K -$71.9K -22.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $264K -$69.2K -20.8% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $282K -$66.5K -19.1% Dec 31, 2020 10-K 2022-03-21
Q3 2020 $300K -$63.9K -17.6% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $317K -$61.4K -16.2% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $333K -$58.9K -15% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $349K +$349K Dec 31, 2019 10-K 2021-03-02
Q3 2019 $364K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $378K Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $392K Mar 31, 2019 10-Q 2019-05-06
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.